Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering-Plough seeks further E.U. approval for Temodal

April 7, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Celgene and NCI collaborate on thalidomide cancer trial

April 6, 1999

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Phase II trials of first anticancer dioxolane nucleoside analogue begin

April 5, 1999

Aronex regains worldwide marketing rights to Atragen

April 1, 1999

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

April 1, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

New microbially produced inhibitor of HSP expression in development at Mercian

April 1, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...